Dr. Ronald J. Carabelli, MD

Dr. Carabelli practices at Pennsylvania Hospital in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Carabelli's NPI, 1932199551, was assigned on October 25, 2005. Dr. Carabelli holds Pennsylvania license MD026950E.

Dr. Carabelli's primary practice is Pennsylvania Hospital, at 800 Spruce Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 829-3000.

Dr. Carabelli's primary practice is Pennsylvania Hospital in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Carabelli is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Carabelli to 3 more hospitals, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carabelli practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Carabelli's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Carabelli is licensed in Pennsylvania.

CMS data shows 3,321 Medicare services from Dr. Carabelli across 15 procedure codes in 2024, for 1,285 Medicare patients. Medicare paid $91,506 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,285 Medicare patients who saw Dr. Carabelli in 2024. The largest group is 65 to 74, with 561 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carabelli's median patient age at 64, with 53% women.

In 2024, Dr. Carabelli wrote 5,326 Medicare Part D claims for 594 patients. 83% of them were for generic drugs. CMS names the drug for 5,083 of them, across 50 drugs with 11 or more claims each, at $839,405 in total drug cost. In 2023, CMS named 4,662 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Carabelli for performance year 2024, reported as part of a group. Dr. Carabelli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 25 general payments to Dr. Carabelli from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $222.